by GlobeNewsWire | Jan 11, 2016 | Globe Newswire, GNW Alerts
ST. LOUIS, Jan. 11, 2016 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it has initiated its first prospective, multi-center, randomized clinical study...
by GlobeNewsWire | Sep 4, 2015 | Globe Newswire, Health Stock, Medical, Medical Stocks
ST. LOUIS, Sept. 4, 2015 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it will conduct a registered offering of subscription warrants to the holders...
by GlobeNewsWire | Aug 27, 2015 | Biotech, Globe Newswire, Health, Medical, Medical Stocks
ST. LOUIS, Aug. 27, 2015 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (NASDAQ:STXS) and Westmead Hospital in Australia today announced findings of a recent study comparing the stability of a Niobe® remote magnetic navigation system catheter group and a manually...